Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDT vs Jessner's Solution and TCA for Actinic Keratoses
NCT04429308Phase 2Not yet recruiting
- Sponsor
- Northwestern University
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aminolevulinic acid 10% gel, Jessner's solution, trichloroacetic acid in actinic keratosis (AK), sponsored by Northwestern University. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
aminolevulinic acid 10% gelJessner's solutiontrichloroacetic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT04429308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04429308.